Woodline Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,519
| Closed | -$173K | – | 1086 |
|
|
2025
Q1 | $173K | Buy |
21,519
+1,873
| +10% | +$15K | ﹤0.01% | 881 |
|
|
2024
Q4 | $190K | Buy |
+19,646
| New | +$190K | ﹤0.01% | 907 |
|
|
2024
Q1 | – | Sell |
-109,174
| Closed | -$1.71M | – | 652 |
|
|
2023
Q4 | $1.71M | Buy |
109,174
+19,319
| +22% | +$302K | 0.02% | 383 |
|
|
2023
Q3 | $4.44M | Buy |
89,855
+14,724
| +20% | +$728K | 0.05% | 327 |
|
|
2023
Q2 | $5.88M | Buy |
75,131
+31,653
| +73% | +$2.48M | 0.07% | 267 |
|
|
2023
Q1 | $3.94M | Sell |
43,478
-3,787
| -8% | -$343K | 0.05% | 323 |
|
|
2022
Q4 | $5.58M | Hold |
47,265
| – | – | 0.07% | 296 |
|
|
2022
Q3 | $8.58M | Hold |
47,265
| – | – | 0.12% | 216 |
|
|
2022
Q2 | $4.24M | Hold |
47,265
| – | – | 0.07% | 284 |
|
|
2022
Q1 | $7.34M | Hold |
47,265
| – | – | 0.12% | 205 |
|
|
2021
Q4 | $14.1M | Sell |
47,265
-16,194
| -26% | -$4.82M | 0.2% | 142 |
|
|
2021
Q3 | $36.6M | Buy |
63,459
+1,464
| +2% | +$844K | 0.6% | 37 |
|
|
2021
Q2 | $28.1M | Buy |
61,995
+10,694
| +21% | +$4.86M | 0.52% | 46 |
|
|
2021
Q1 | $27.6M | Buy |
51,301
+6,089
| +13% | +$3.28M | 0.61% | 50 |
|
|
2020
Q4 | $40M | Sell |
45,212
-6,571
| -13% | -$5.81M | 1.06% | 25 |
|
|
2020
Q3 | $32.8M | Buy |
+51,783
| New | +$32.8M | 1.07% | 28 |
|